Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 2,797.60
+16.30 (0.59%)
Apr 21, 2026, 3:30 PM IST
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 348.59 billion as of April 21, 2026. Its market cap has increased by 2.29% in one year.
Market Cap
348.59B
Enterprise Value
341.64B
Revenue
52.02B
Ranking
n/a
PE Ratio
34.37
Stock Price
2,797.60
Market Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 348.59B, an increase of 61,510.01%. That is a compound annual growth rate of 30.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 347.35B | 0.45% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 667.41B |
| Glenmark Pharmaceuticals | 634.81B |
| Laurus Labs | 613.14B |
| Ipca Laboratories | 372.51B |
| Emcure Pharmaceuticals | 317.01B |
| Gland Pharma | 296.13B |
| Wockhardt | 226.73B |
| NATCO Pharma | 200.55B |